Business

In this article F GM A sign is unveiled at General Motors Detroit-Hamtramck Assembly on Oct. 16, 2020, introducing the facility’s new name: Factory Zero, Detroit-Hamtramck Assembly Center. GM After years of come-and-gone predictions that battery-powered sedans, pickups and SUVs would replace gas-guzzling, emissions-spewing models, the shift to electric vehicles is revving up. Beyond EV
0 Comments
In this article NGCA SPCE Richard Branson’s Virgin Orbit, with a rocket under the wing of a modified Boeing 747 jetliner, takes off for a key drop test of its high-altitude launch system for satellites from Mojave, California, July 10, 2019. Mike Blake | Reuters Virgin Orbit, the satellite-launching spinoff of Sir Richard Branson’s Virgin
0 Comments
In this article DISCA Anthony Ramos and Melissa Barrera star as Usnavi de la Vega and Vanessa in the film adaption of “In the Heights.” Warner Bros. “In the Heights” is a celebration of love, life and community, critics say. The film adaptation of Lin-Manuel Miranda’s Tony Award-winning musical currently holds at 97% “Fresh” rating
0 Comments
SINGAPORE — The public listings for two of Southeast Asia’s tech giants will likely pave the way for more high-growth businesses to emerge from the region, said venture capital firm 500 Startups. Contrary to concerns that regional heavyweights may “gobble up” smaller start-ups and stymie innovation, Vishal Harnal told CNBC that “couldn’t be further from
0 Comments
Kevin Aluwi and William Tanuwijaya recently made Indonesian history. As founding members of GoTo Group, the 30-somethings are responsible for creating Indonesia’s newest and most valuable tech company after merging their ride-hailing and e-commerce start-ups in the country’s biggest-ever business deal. The combined entity contributes 2% to Indonesia’s GDP via its various business lines including
0 Comments
A person skateboards past Biogen Inc. headquarters in Cambridge, Massachusetts, on Monday, June 7, 2021. Adam Glanzman | Bloomberg | Getty Images Biogen on Tuesday faced tough questions from Wall Street analysts over the $56,000 annual cost of its newly approved Alzheimer’s drug Aduhelm – a price tag executives are calling “fair” and “responsible.” Shares
0 Comments
In this article BIIB Dementia expert Dr. Jason Karlawish told CNBC he’s skeptical of the Food and Drug Administration’s approval of Biogen‘s Alzheimer’s disease drug, Aduhelm, saying “the evidence to approve the drug wasn’t sufficient.” “Another study is needed to establish whether this drug, in fact, is effective. Unfortunately, the FDA approved the drug for
0 Comments
Interactive Brokers Group, Inc. Chairman and CEO Thomas Peterffy. Mike Segar | Reuters Interactive Brokers founder and chairman Thomas Peterffy on Monday issued a warning to investors betting against so-called meme stocks like AMC Entertainment. “It is extremely tempting to short these stocks, but unless you have huge liquid resources, please try to resist the temptation
0 Comments
Medical researchers say within a few years major breakthroughs in blood testing technology that use immune system response and genetic analysis to identify disease quickly and cost-effectively will be on the market. picture alliance | picture alliance | Getty Images One morning last May, Tayah Fernandes’s mother Shannon realized her four-year-old daughter was seriously unwell,
0 Comments
Dr. Scott Gottlieb pointed on Friday to the highly transmissible Covid-19 variants as a potential cause behind an increase in adolescents being hospitalized with the virus in March and April.  “It’s concerning, the trends on hospitalizations” among teenagers, said Gottlieb, the former Food and Drug Administration chief during the Trump administration. “I think it’s a
0 Comments